Komori
Zacros (7917) · InitiativeRestated

Enhancing Pharmaceutical Packaging Functionality and Supporting Medication Safety

First written in FY2017. 2 of 4 entries say "Advanced", first in FY2018. Latest entry: FY2022-Q3.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017AdvancedFY2018 – FY20192017: 120172018: 120182019: 120192020: 020202021: 020212022: 1
Same theme, other companies
Enhancing Pharmaceutical Packaging Functionality and Supporting Medication SafetyA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022-Q3RestatedAnnual report

    「Sales of single-use bags and related products for manufacturing biopharmaceuticals and other products also remained strong, resulting in higher overall business revenue.」

    The Company reaffirmed strong sales of single-use bags and related products for manufacturing biopharmaceuticals and other products.
  2. FY2019AdvancedAnnual report

    「Alongside measures addressing accidental ingestion of PTP packs by children, we are working with universities and companies to develop new products that meet the social need for packaging from which older people can easily remove the contents. We are also submitting presentations and papers to academic conferences to obtain external evaluation, while conducting public relations activities.」

    For packaging addressing accidental ingestion by children and the needs of older people, development with universities and companies progressed through conference presentations, paper submissions, and obtaining external evaluation.
  3. FY2018AdvancedAnnual report

    「Alongside measures addressing accidental ingestion of PTP packs by children, we are working with universities and companies to develop new products that meet the social need for packaging from which older people can easily remove the contents. We have also begun developing an ultra-high-moisture-barrier multilayer film that can be molded as a core technology, started providing some samples this fiscal year, and are developing the market.」

    In addition to addressing accidental ingestion by children and ease of use for older people, development of an ultra-high-moisture-barrier multilayer film had begun and sample provision had started.
  4. FY2017First statedAnnual report

    「In addition to enhancing the functionality of odor-absorbing, oxygen-absorbing, easy-open, and UV-blocking packaging, we are working with universities and companies to develop an evaluation system for gastrointestinal damage in the event of accidental ingestion and to improve medication adherence, as accidental ingestion of pharmaceuticals has become a social issue.」

    The Company listed development themes addressing enhanced pharmaceutical packaging functionality, assessment of damage from accidental ingestion, and improved medication adherence.
Moved together

"Developing New Technologies and Products Through the Integration of Technologies" moved the same way as this thread, in the same document, in 2 of its 4 moves.

22★12
  1. ★This thread
  2. 1Developing New Technologies and Products Through the Integration of Technologies2×
  3. 2Development and Sales of Materials for Lithium Secondary Batteries2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zacros's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.